Remission of severe autoimmune bullous disorders induced by long-term extracorporeal photochemotherapy.

[1]  L. French,et al.  Extracorporeal photopheresis: past, present, and future. , 2009, Journal of the American Academy of Dermatology.

[2]  Michael Y. Gerner,et al.  Extracorporeal Photopheresis Efficiently Impairs the Proinflammatory Capacity of Human 6-Sulfo LacNAc Dendritic Cells , 2009, Transplantation.

[3]  E. Gatza,et al.  Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells. , 2008, Blood.

[4]  P. R. Mydlarski,et al.  Advances in pemphigus therapy. , 2008, Skin therapy letter.

[5]  A. Balduzzi,et al.  Extracorporeal Photochemotherapy Is Accompanied by Increasing Levels of Circulating CD4+CD25+GITR+Foxp3+CD62L+ Functional Regulatory T-Cells in Patients With Graft-Versus-Host Disease , 2007, Transplantation.

[6]  J. Buer,et al.  Inhibition of the Transcription Factor Foxp3 Converts Desmoglein 3-Specific Type 1 Regulatory T Cells into Th2-Like Cells1 , 2006, The Journal of Immunology.

[7]  S. Ibbotson,et al.  Evidence‐based practice of photopheresis 1987–2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group , 2006, The British journal of dermatology.

[8]  V. Werth,et al.  Pemphigus: A treatment update , 2006, Autoimmunity.

[9]  Y. Aragane,et al.  Intravenous Infusion of Syngeneic Apoptotic Cells by Photopheresis Induces Antigen-Specific Regulatory T Cells 1 , 2005, The Journal of Immunology.

[10]  E. Giorda,et al.  The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. , 2005, Transplantation.

[11]  G. Schuler,et al.  Type I Regulatory T Cells Specific for Desmoglein 3 Are More Frequently Detected in Healthy Individuals than in Patients with Pemphigus Vulgaris1 , 2004, The Journal of Immunology.

[12]  M. Albert.  Death-defying immunity: do apoptotic cells influence antigen processing and presentation? , 2004, Nature Reviews Immunology.

[13]  S. Zheng,et al.  CD4+ and CD8+ Regulatory T Cells Generated Ex Vivo with IL-2 and TGF-β Suppress a Stimulatory Graft-versus-Host Disease with a Lupus-Like Syndrome1 , 2004, The Journal of Immunology.

[14]  A. O’Garra,et al.  Twenty-first century Foxp3 , 2003, Nature Immunology.

[15]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[16]  John Savill,et al.  A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.

[17]  A. Buchman.  Side Effects of Corticosteroid Therapy , 2001, Journal of clinical gastroenterology.

[18]  J. Bluestone,et al.  Suppressor T cells – they’re back and critical for regulation of autoimmunity! , 2001, Immunological reviews.

[19]  M. Roncarolo,et al.  Type 1 T regulatory cells , 2001, Immunological reviews.

[20]  A. Ahmed,et al.  Emerging treatment for epidermolysis bullosa acquisita. , 2001, Journal of the American Academy of Dermatology.

[21]  J. Piette,et al.  [Resistant acquired bullous epidermolysis with severe ocular involvement: the success of extracorporeal photochemotherapy]. , 1999, Annales de dermatologie et de vénéréologie.

[22]  U. Wollina,et al.  Short-Time Extracorporeal Photochemotherapy in the Treatment of Drug-Resistant Autoimmune Bullous Diseases , 1999, Dermatology.

[23]  R. F. de Misa,et al.  Severe pemphigus foliaceus treated with extracorporeal photochemotherapy. , 1997, Archives of dermatology.

[24]  K. Gordon,et al.  Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy , 1997, The British journal of dermatology.

[25]  H. Gollnick,et al.  [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases]. , 1996, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[26]  H. Griesser,et al.  Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.

[27]  J. Miller,et al.  Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy , 1995, The British journal of dermatology.

[28]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[29]  F. Kerdel,et al.  Pemphigus vulgaris treated with photopheresis. , 1992, Journal of the American Academy of Dermatology.

[30]  F. Trautinger,et al.  Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study. , 1992, Arthritis and rheumatism.

[31]  D. Woodley,et al.  Autoimmunity to type VII collagen. , 1991, Seminars in dermatology.

[32]  D. Woodley,et al.  Acquired epidermolysis bullosa. A bullous disease associated with autoimmunity to type VII (anchoring fibril) collagen. , 1990, Dermatologic clinics.

[33]  A. Rook,et al.  Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. , 1990, Annals of internal medicine.

[34]  W. Macey,et al.  Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris--preliminary report. , 1989, The Yale journal of biology and medicine.

[35]  L. Laroche,et al.  Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. , 1989, The Journal of investigative dermatology.

[36]  K Wolff,et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.

[37]  S. Yeh,et al.  Treatment of Pemphigus Vulgaris , 2005, American journal of clinical dermatology.

[38]  K. Wood,et al.  Regulatory lymphocytes: Regulatory T cells in transplantation tolerance , 2003, Nature Reviews Immunology.

[39]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.

[40]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.

[41]  H. Gollnick,et al.  Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis. , 1993, Journal of the American Academy of Dermatology.